ACA
IMGN

Avoro Capital Advisors’s Immunogen Inc IMGN Stock Holding History

Avoro Capital Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-875,000
Closed -$25.9M – 52
2023
Q4 		$25.9M Buy
+875,000
New +$17.4M 0.36% 33
2020
Q2 		– Sell
-1,900,000
Closed -$6.48M – 52
2020
Q1 		$6.48M Buy
+1,900,000
New +$8.31M 0.22% 39

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Avoro Capital Advisors's IMGN Position: Q1 2024 in Review

Avoro Capital Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 875,000 shares — an estimated $25.9M sold.

Avoro Capital Advisors first reported a position in IMGN in Q1 2020 and held it in 2 quarters. The position peaked at $25.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Avoro Capital Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Avoro Capital Advisors sold 875,000 Immunogen Inc shares in Q1 2024, an estimated $25.9M.
  • Avoro Capital Advisors first reported a position in Immunogen Inc in Q1 2020 and held it in 2 quarters.
  • Avoro Capital Advisors's Immunogen Inc position peaked at $25.9M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Avoro Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.